Lupus

Fast Facts | Key Research | More Resources
   

Lupus: Fast Facts

Find a Clinical Trial

Learn more about autoimmune diseases at the Seattle Cancer Care Alliance.

[ Back to Top ]
   

Lupus: Some of our Key Research

Using transplantation to treat severe autoimmune diseases
Dr. Richard Nash and colleagues are leading clinical trials to examine the feasibility of high-dose chemotherapy and stem-cell transplantation — the standard treatment for leukemia and other blood cancers — in treating severe forms of autoimmune diseases, including multiple sclerosis, systemic lupus erythematosus and scleroderma (also known as systemic sclerosis). Their early results have been promising, prompting larger studies.

With transplantation, it may be possible to remove the reactive cells that trigger the immune system to attack the body. In such a transplantation, a patient's stem cells are collected, and cells that react against the patient's own tissue are removed. Next, the patient undergoes high-dose chemotherapy and takes drugs to suppress their immune system. The patient then receives an infusion of the stem cells that were collected before treatment, with the goal of rebuilding a new, healthier immune system. Learn more. »

[ Back to Top ]
   

Lupus: More Resources

[ Back to Top ]

Fred Hutchinson Cancer Research Center
1100 Fairview Ave. N. PO Box 19024 Seattle, WA 98109
©2009 Fred Hutchinson Cancer Research Center, a nonprofit organization.
Terms of Use & Privacy Policy.

CenterNetCheck E-mail